- Jan 27, 2014
- 6,894
- 8
- 0
,... but, this pill injection will - says CEO of the company that will make said pill.
http://www.cnbc.com/id/101929948#.
Oh,.. and it's not your fault,...
http://www.cnbc.com/id/101929948#.
"Treating obesity with dietary prevention and exercise is like putting sunscreen on melanoma. It's too late," Hughes told CNBC. "People who have established obesity, they will need treatments, they will need care to get out of that, and unless we wake up to that fact and understand and research what is at the heart of that problem, we're not going to have an answer."
Oh,.. and it's not your fault,...
Zafgen's compound, beloranib, is in mid-stage trials in obesity and is also in testing for a rare disease called Prader-Willi Syndrome, a genetic disorder characterized by an uncontrollable drive to eat. It works in a different way from the other three medicines, which aim to reduce appetite; "it works to really impact the way that the body handles fat," Hughes said.
He added that one of the biggest hurdles facing obesity drugs is a bias against treating obesity as a disease, something he believes needs to change.
"In general over the years, people have regarded obesity as a problem of the patient," Hughes said, "that it's their responsibility for becoming obese and it's their responsibility to become lean again, as if that works."
Last edited: